Key segments of the global 3D cell culture market

The 3D cell culture is an artificially created environment where biological cells are allowed to grow and interact with their surroundings. 3D cell culture is being increasingly adopted due to its convenient and new features when compared to the 2D cell culture model. In a 3D environment, cells are subjected to better morphological and physiological changes than in a 2D environment.

The advantages offered by the 3D cell culture in comparison to the 2D cell culture model is driving the global 3D cell culture market. The global 3D cell culture market can be segmented based on product, end-user, application and region.

Based on the product, the global 3Dcell culture market is segmented into scaffold-based 3D cell culture, scaffold-free 3D cell culture, microfluidics-based 3D cell culture, and magnetic levitation and 3D bio printing. The scaffold-based 3D cell culture product segment will dominate the market during the 2018-2023 period with a market share of 36.6 %.The high demand for this segment is attributed to its ability to impersonate in vivo conditions for the cell culture.

Based on the application, the global 3D cell culture market is segmented into cancer and stem cell research, drug discovery and toxicology, tissue engineering and regenerative medicine. Depending on the end users, the 3D cell culture model has been adopted by hospitals, diagnostic centres, pharmaceutical, and biotech companies. The biotechnology and pharmaceutical companies dominated the market with a revenue of USD 0.77 Bn and 67% market share in 2017.

Geographically North America held 41.8% of the global 3D cell culture market in 2017. This is due to a large number of cancer incidences and ongoing research activities in this region. Europe and the Asia Pacific will follow North America in terms of high CAGR, owing to rising number of contract research activities and fund allocation for research and development activities.